Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I’ mode
Bernhard Gillissen(Heidelberg University), P T Daniel(Humboldt-Universität zu Berlin)
Cited by 46
Related Papers
Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma
|Journal of Biological Chemistry|2017|51